SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Endovascular Atherectomy in Peripheral Artery Disease, Coronary Artery Disease, and Non-Atherosclerotic Vascular Conditions: Scoping Review with ☸️SAIMSARA

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsara99fa2e74

Editorial note
• Last update: 2026-06-20 10:43:41
What is this paper about
Endovascular atherectomy delivers high technical success across peripheral, coronary, and selected non-atherosclerotic vascular conditions, yet its long-term clinical advantage remains highly dependent on anatomy, device, and treatment strategy. The full review reveals where atherectomy adds real value, where risks and reinterventions rise, and which applications remain unsupported.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.


Generated with SAIMSARA v5.1

Abstract: To comprehensively map the clinical evidence on endovascular atherectomy across peripheral artery disease, coronary artery disease, and non-atherosclerotic vascular conditions, synthesizing data on technical success, clinical outcomes, reintervention, and safety across different devices, anatomical segments, and clinical indications, while also characterizing practice patterns and health-system implications. The review uses 172 references and builds its evidence map from 302 original studies with 1732527 total participants/sample observations (topic-deduplicated ΣN). This scoping review indicates that endovascular atherectomy reliably achieves high acute technical success in complex, calcified lesions but does not consistently translate into superior long-term outcomes compared with angioplasty or stenting, with adjusted safety endpoints showing no significant difference (aHR 0.99). The evidence supports a role for atherectomy chiefly as a lesion-preparation adjunct to drug-coated balloon therapy rather than a standalone strategy, while highlighting a replicated trade-off of increased reintervention (aHR 1.21) and elevated distal embolization. A more favorable signal emerges in isolated popliteal disease, where atherectomy was associated with higher freedom from major amputation. These patterns, alongside utilization shifts toward office-based settings driven by non-clinical factors, warrant scrutiny of appropriateness. Randomized trials with standardized endpoints are needed to clarify where selective atherectomy genuinely improves limb outcomes.
.

Keywords: endovascular atherectomy; peripheral artery disease; femoropopliteal lesions; drug-coated balloon; target lesion revascularization; major adverse limb events; rotational atherectomy; in-stent restenosis; chronic limb-threatening ischemia; below-the-knee intervention

Review Stats

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (172)

Unlock the full paper to view the complete Reference Index.